Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the WorldLOS ANGELES, Nov. 5, 2026 /PRNewswire/ -- Spinogenix, Inc.,...
SiOxMed's clinical hydration science and Gifthealth's pharmacy services platform together give patients with atopic dermatitis and allergic contact dermatitis a...
Global regulatory affairs leader with 30 years in the pharmaceutical industry, including 28 years in regulatory affairs spanning development, registration,...
Arlington, Virginia--(Newsfile Corp. - November 5, 2026) - The AAMI Foundation today announced it has received a $50,000 contribution from...
The Best FFS Surgeon in the U.S. is Dr. Javad Sajan SEATTLE, WA / ACCESS Newswire / November 5, 2026...
Multi-year agreements expand iDoc subsidiary's delivery of tele-ICU services and teleradiology platform solutions HOUSTON, TX / ACCESS Newswire / November...
Board-certified oral surgeons explain why early assessment matters, and what local patients and referring dentists should know about timing, risks,...
WOONSOCKET, RI / ACCESS Newswire / November 5, 2026 / Originally published on CVS Health Company NewsroomHigh blood pressure, also...
Refined priming-dose regimen addresses important treatment-tolerability objective identified through FDA discussions, further strengthening mipletamig's readiness for Phase 2 developmentSubstantial reduction...
- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty...
Xycota's lead program aims to deliver clinical benefit from low-dose psilocybin without hallucinogenic effects, with mild PTSD as its initial...
New order-processing line: automated handling cell and roller conveyor now being commissioned at CosmoFarm's distribution center in Peristeri, Athens, designed...
Alethio Therapeutics Rohit Batta, CEO Series A financing co-led by Sofinnova Partners and RA Capital alongside founding investor Oxford Science...
$133 million Series B financing co-led by new investors Advent Life Sciences and British Business Bank, with additional new investments...
Egetis Therapeutics’ lead asset, EMCITATE®, is the first and only approved treatment in U.S. and Europe for peripheral thyrotoxicosis associated...
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update Ongoing negotiations with different parties towards securing a partnership...
The project in Assam marks an important milestone in expanding access to advanced cancer care in India Louvain-La-Neuve, Belgium, November...
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
— Eligible for development incentives including 7 years of US market exclusivity upon regulatory approval — — Marks the second...
ROCKVILLE, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated...